Search the Newsreel

Analyst Estimates: Here's What Brokers Think Of BridgeBio Pharma, Inc. (NASDAQ:BBIO) After Its Second-Quarter Report

This article analyzes what brokers think of BridgeBio Pharma, Inc. (NASDAQ:BBIO) following its second-quarter report. It would likely detail analyst ratings, price targets, and any changes in sentiment post-earnings, providing insights into the company's financial performance and future outlook from an investment perspective.

Oxbridge Re Holdings Limited Q2 2026 Earnings Call Summary

Oxbridge Re Holdings Limited Q2 2026 Earnings Call Summary - Moby Strategic Evolution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. …

Bridgeline Digital (BLIN) Edges Higher by 0.92% as Range-Bound Trade Persists - Take Profit Levels

WaterBridge (WBI) Raised Guidance Again, So Why Did Shares Slip?

WaterBridge Infrastructure (NYSE:WBI) just posted record quarterly revenue, raised its full-year outlook for the second straight quarter, and closed a wave of acquisitions that doubled its waste management footprint in the Delaware Basin. Yet the stock fell 1.73% around the release. For a produced …

BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base

BridgeBio Pharma, Inc. announced the pricing of an oversubscribed secondary offering of 5,000,000 shares of its common stock by KKR Genetic Disorder L.P. The company itself is not selling shares and will not receive any proceeds from the offering. This transaction aims to further …

KKR to Sell 5M BridgeBio Shares; Company Receives No Proceeds

BridgeBio Pharma announced the pricing of a secondary offering of 5,000,000 shares of its common stock by existing shareholder KKR Genetic Disorder L.P. BridgeBio will not issue any shares or receive any proceeds from this transaction, which is expected to close on August 17, …

BridgeBio Pharma (BBIO) holders to resell 5M shares in $390M offering

BridgeBio Pharma is facilitating a secondary offering where a KKR-affiliated selling stockholder will sell 5,000,000 shares of common stock at $78.00 per share, totaling $390 million. BridgeBio Pharma will not receive any proceeds from this transaction, as all net proceeds will go to the …

NewEdge Advisors LLC Sells 11,629 Shares of Broadridge Financial Solutions, Inc. $BR

NewEdge Advisors LLC reduced its stake in Broadridge Financial Solutions Inc. by 43.7% in the first quarter, selling 11,629 shares and retaining 15,012 shares valued at approximately $2.44 million. Broadridge reported strong quarterly earnings, exceeding analyst estimates, and increased its quarterly dividend from $0.97 …

Oxbridge Re earnings missed by $0.05, revenue fell short of estimates

Comet Ridge (ASX:COI) Plummets as Gas Developer Selling Accelerates

QV Investors Inc. Sells 34,230 Shares of Enbridge Inc $ENB

QV Investors Inc. reduced its stake in Enbridge Inc. (NYSE:ENB) by 4.7% during the second quarter, selling 34,230 shares but still holding 696,095 shares valued at $37.7 million. Enbridge reported quarterly earnings of $0.46 per share, surpassing estimates, and declared a quarterly dividend of …

Oxley Bridge Acquisition (OBA) earns $4.3M on Trust but faces 2027 deadline

Oxley Bridge Acquisition Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Western Wealth Management LLC Makes New Investment in Broadridge Financial Solutions, Inc. $BR

Western Wealth Management LLC recently acquired a new stake in Broadridge Financial Solutions, purchasing 5,902 shares valued at approximately $959,000. Broadridge Financial Solutions has received a "Moderate Buy" consensus rating from analysts, with an average price target of $213.71, and the company exceeded quarterly …

Corebridge Financial, Inc. $CRBG Shares Sold by Royal Bank of Canada

Exchange Traded Concepts LLC Sells 89,348 Shares of Enbridge Inc $ENB

Exchange Traded Concepts LLC reduced its stake in Enbridge Inc. by 7.2% in the second quarter, selling 89,348 shares and retaining 1.14 million shares valued at approximately $62 million. Enbridge reported strong quarterly results, beating analyst expectations for both EPS and revenue, and declared …

BAER|Bridger Aerospace Group Holdings Inc|Price:1.245|Chg%:+0.045

BRID|Bridgford Foods Corp|Price:6.420|Chg%:+0.050

Comet Ridge Tumbles As Dilution Fears Grip Investors

Broadridge Financial Solutions, Inc. (NYSE:BR) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Broadridge Financial Solutions, Inc. (NYSE:BR) has received a "Moderate Buy" consensus recommendation from brokerages, with an average 12-month price target of $213.71. The company recently surpassed quarterly earnings expectations, reporting adjusted EPS of $3.82 and revenue of $2.22 billion, a 7.5% increase year-over-year. Broadridge …

Seabridge Gold Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Blackstone Holdings II L.P. sells $2.89M in Bridger Aerospace shares

Glazer Capital (DBRG) discloses 2.70% beneficial stake in DigitalBridge Group

Glazer Capital, LLC and its managing member, Paul J. Glazer, have reported a 2.70% beneficial ownership stake in DigitalBridge Group, Inc. (DBRG), amounting to 4,927,041 shares of Class A common stock. The shares are held by funds and managed accounts where Glazer Capital acts …

Granite Ridge Resources (GRNT) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, Aug. 7, 2026 at 11 a.m. ET CALL PARTICIPANTS Vice President, Investor Relations - James MastersPresident and Chief Executive Officer - Tyler FarquharsonChief Financial Officer - Kyle Kettler TAKEAWAYS Daily Production -- 32,044 barrels of oil equivalent …

Bridger Aerospace (BAER) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Chief Financial Officer - Anne HayesPresident and Chief Executive Officer - Sam Davis TAKEAWAYS Revenue -- $30.5 million, representing a 1% decrease from $30.8 million primarily due to …

Comet Ridge Limited Applies to Quote 91.8 Million Ordinary Shares from Placement

NovaBridge Biosciences to report H1FY26 results on Aug 20

NovaBridge Biosciences (NASDAQ: NBP) will hold a webcast on August 20, 2026, to discuss its financial results for the first half ended June 30, 2026, and provide a corporate update. The company, focused on oncology and ophthalmology programs, will host the webcast at 9:00 …

Oxbridge outlines AI GridWorks targeting 10-100 MW data center projects while expanding tokenized reinsurance offerings

Earnings Call Insights: Oxbridge Re Holdings Limited (OXBR) Q2 2026 MANAGEMENT VIEW * "During the second quarter and subsequent period, we continued to build on the growth of our tokenized reinsurance business, expanded the platform to include third-party opportunities and established a new AI …

Comet Ridge Completes Tranche 2 Placement and Resets Warrant Terms

Bridgford Foods (BRID) Slips 2.5% as Shares Test Key Support Near $5.85 - VWAP Breakout

Comet Ridge Issues 195 Million Unquoted Options Under Existing Deal

Comet Ridge Seeks ASX Quotation for 91.8 Million New Shares

Comet Ridge Issues New Unquoted Options Expiring in 2028

Seabridge Gold Arranges Up to US$100M for Summer Field Work

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

BridgeBio Pharma, Inc. (Nasdaq: BBIO) has announced a secondary public offering of 5,000,000 shares of its common stock by KKR Genetic Disorder L.P., an existing shareholder. BridgeBio itself is not selling any shares and will not receive any proceeds from this offering. William Blair, …

KKR Proposes Sale of 5 Million BridgeBio Pharma Shares in Offering

BridgeBio Pharma (BBIO) announced a secondary public offering of 5,000,000 shares of its common stock, to be sold by existing shareholder KKR Genetic Disorder L.P. BridgeBio will not sell any shares in this transaction and will not receive any proceeds. The offering is subject …